BioSpace News Archive

Business

PTC Therapeutics to Host Conference Call to Discuss Third Quarter 2018 Financial Results

PTC Therapeutics, Inc. today announced that the Company will host a webcast conference call to report its third quarter 2018 financial results and provide an update on the company’s business and outlook on Monday, November 5, 2018 at 4:30 p.m. (ET) after closing of the market.

October 22, 2018
·
1 min read
Policy

ResMed Wins German Patent Infringement Case Against Fisher & Paykel

Court finds headgear used on Simplus and Eson 2 CPAP masks infringes ResMed patent

October 22, 2018
·
1 min read
Genetown

A 2015 Guideline Recommending Removal of Only Half the Thyroid Gland Grows in Use, Benefits Patients with Thyroid Cancer

Study findings show a growing trend among surgeons to shift to a less invasive operation, with fewer risks for thyroid cancer patients

October 22, 2018
·
5 min read
Drug Development

Investigational Subcutaneous Formulation of Vedolizumab Achieves and Maintains Clinical Remission and Mucosal Healing at Week 52 in Patients with Moderately to Severely Active Ulcerative Colitis

Additional subgroup analysis shows subcutaneous formulation of vedolizumab achieves significantly higher clinical remission rates to placebo in anti-TNFα-naïve patients

October 22, 2018
·
13 min read
Pharm Country

IAVI and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products for HIV

Collaboration to develop optimal combination of HIV-specific antibodies and ensure that cost is not a barrier to access

October 22, 2018
·
8 min read
Drug Development

BerGenBio Announces Interim Biomarker and Phase II Clinical Data with Selective AXL Inhibitor Bemcentinib Presented at ESMO

Biomarker predicts clinical benefit rate of 70% and overall response rate of 40% in second line NSCLC

October 22, 2018
·
6 min read
Business

Anaeropharma Science Signs Collaborative Research Agreement with Chugai on Creation of Novel Oncology Drugs Using Bifidobacterium

Anaeropharma Science Inc. announced on October 22 that Anaeropharma Science and Chugai Pharmaceutical Co., Ltd. headquartered in Tokyo (hereinafter “Chugai”) have concluded a collaborative research agreement concerning the creation of novel oncology drugs utilizing characteristic features of Bifidobacterium longum through Anaeropharma’s proprietary platform technology, “in situ Delivery and Production System” (hereinafter “i-DPS”).

October 22, 2018
·
2 min read
Business

Vivior Chairman Receives Award for Outstanding Contributions to Refractive Surgery

Michael Mrochen, PhD, Chairman of the Board of Directors at Vivior, receives the Casebeer Award from the International Society of Refractive Surgery.

October 22, 2018
·
2 min read
Business

CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplant

Collaboration Combines CollPlant’s Proprietary rhCollagen-based Bioink Technology and United Therapeutics’ Regenerative Medicine and Organ Manufacturing Capabilities

October 22, 2018
·
7 min read
BioForest

Aortica™ Corp. Announces Publication of Successful Results Demonstrating Simplification of Fenestrated EVAR Using AortaFit™ Automated Case Planning Software

Dr. Benjamin Starnes’ PS-IDE Study Results published in Journal of Vascular Surgery

October 22, 2018
·
4 min read